When seeking high-purity chemical compounds for pharmaceutical research and development, identifying a dependable manufacturer and supplier is paramount. (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride, identified by CAS number 331763-59-8, is one such critical intermediate. This compound plays a significant role in medicinal chemistry due to its structural characteristics and potential biological activities.

For procurement professionals and R&D scientists, understanding the key attributes and sourcing options for this compound is crucial. The primary appearance of (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride is typically described as an off-white to white solid or powder, with a reported purity often around 97%. These specifications are vital for ensuring the integrity and efficacy of downstream synthesis and research applications.

The compound's significance lies in its potential as a GABA receptor agonist. This property makes it a valuable tool for investigating neurological disorders, including conditions characterized by muscle spasticity. Researchers in pharmaceutical companies often look to buy such compounds to explore new therapeutic avenues. For those needing to purchase this intermediate, it's essential to connect with established suppliers who can guarantee quality and consistency.

When considering a purchase, factors such as price, availability, and the supplier's reputation are key. Many global buyers turn to manufacturers in China for cost-effectiveness and robust supply chains. Identifying a reputable Chinese supplier for (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride ensures that you receive materials that meet international standards. These suppliers often provide detailed technical data, including molecular formula (C10H13Cl2NO2) and molecular weight (250.12), aiding in precise application and handling.

For companies looking to buy in bulk or establish a long-term supply agreement, engaging directly with manufacturers is beneficial. This approach often leads to better pricing and more personalized service, addressing specific batch requirements or quality control parameters. The market for pharmaceutical intermediates is competitive, and choosing the right partner can significantly impact project timelines and budgets.

In summary, for any R&D or manufacturing operation requiring (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride, focusing on quality, supplier reliability, and competitive pricing is essential. By partnering with experienced manufacturers and suppliers, you can secure the necessary materials to drive your pharmaceutical innovations forward.